Key result
This review summarizes the functional consequences of mutations and polymorphisms in the PAF-AH gene based on in vitro biochemical, molecular, and clinical analyses.
This review summarizes the functional consequences of genetic variations in the PAF-AH gene based on biochemical, molecular, and clinical studies.
PAF-AH variants should not yet guide therapy; leaves open targeted trials linking genotypes to cardiovascular outcomes.
In the past several years a number of alterations in the PAFAH/PLA₂G7/LpPLA₂ gene have been described. These include inactivating mutations, polymorphisms in the coding region, and other genetic changes located in promoter and intronic regions of the gene. The consequences associated with these genetic variations have been evaluated from different perspectives, including in vitro biochemical and molecular studies and clinical analyses in human subjects. This review highlights the current state of the field and suggests new approaches that can be used to evaluate functional consequences associated with mutations and polymorphisms in the PAF-AH gene.
No takes yet. Share an insight, caveat, or question.
Diana M. Stafforini (2009) conducted a review in Mutations and polymorphisms in the PAF-AH gene. Mutations and polymorphisms in the PAF-AH gene was evaluated. This review summarizes the functional consequences of mutations and polymorphisms in the PAF-AH gene based on in vitro biochemical, molecular, and clinical analyses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: